Symptoms
Vaginal dryness and GSM in Malta
Vaginal dryness is the most under-treated menopause symptom — and unlike hot flushes, it does not fade on its own. It is part of GSM, the genitourinary syndrome of menopause, which is progressive: without treatment the tissue change tends to worsen, not settle. Low-dose vaginal (local) estrogen treats it directly, and international menopause societies regard it as appropriate for most women, including many breast-cancer survivors, in discussion with their doctors. In Malta it is private-pay, and stock varies — so phone ahead.
Last verified: 10 July 2026 · positions checked against international menopause society guidance; access checked against the Government Formulary · re-verified quarterly
What is GSM — and why the name changed?
GSM stands for genitourinary syndrome of menopause. It's the umbrella term for what falling oestrogen does to the vulvovaginal and lower urinary-tract tissues: dryness, burning, itching, pain during or after sex, urinary urgency, and recurrent urinary tract infections. The term replaced the older "vaginal atrophy" precisely because the changes reach the bladder and urethra too — this was never just about the vagina, and the newer name stops women filing it under "cosmetic."
Prof Mark Brincat, the internationally significant Maltese authority on menopause, built his research lineage on exactly this territory: oestrogen's effect on collagen and connective tissue — skin, bone, and the connective structures that GSM erodes. The tissue thinning is physiological, documented, and reversible with treatment.
Does vaginal dryness go away on its own?
No — and this is the fact that changes how you treat it. Hot flushes, for most women, eventually fade. GSM does the opposite: it is progressive, tending to worsen over the years after your final period rather than resolve. Waiting is not a strategy here. That single difference is why GSM keeps showing up in the postmenopause stages — early postmenopause onward — long after the "storm" symptoms have quietened.
It's the most under-treated menopause symptom largely because it is the most under-reported. Between Malta's Catholic-conservative reticence about these topics and a general assumption that it's just an inevitable part of ageing, many women never raise it. It is treatable. Not raising it is the only part that isn't fixable.
What treats it — and is vaginal estrogen safe?
The targeted treatment is low-dose vaginal (local) estrogen — a cream, pessary or ring applied directly to the tissue. It works locally, with minimal absorption into the bloodstream, which makes it different from systemic HRT. Non-hormonal vaginal moisturisers and lubricants also help and can be used alongside it.
On safety, the recognised professional position is worth stating clearly: international menopause societies regard local vaginal estrogen as appropriate for most women with GSM, and many bodies consider it suitable for many breast-cancer survivors, ideally decided together with their oncology team. We state this as a documented position, not as personal advice — what's right for you depends on your history and belongs in a consultation with your own doctors.
Getting it in Malta
Vaginal estrogen for menopause is private-pay in Malta — it isn't on the Government Formulary for menopause (the formulary covers estrogens only for named conditions like Turner syndrome and hypogonadism, not menopause). A GP or gynaecologist prescribes it; you fill it at a community pharmacy. HRT stock is volatile, so phone the pharmacy first to confirm your product. And if a specific product isn't marketed in Malta, a consultant can request it through the named-patient route (Exceptional Medicinal Treatment, L.N. 58 of 2018) — knowing that route exists changes the conversation when a pharmacist says "we don't stock that here."
When should I see a doctor?
Raise GSM with a doctor whenever dryness, discomfort, painful sex or urinary symptoms are affecting you — you do not need to wait until it's severe, and there's no threshold you have to reach to deserve treatment. See a doctor sooner if you have recurrent UTIs, any bleeding (which always needs checking on its own), or pain that's changing. In Malta, start with a health-centre GP or a private gynaecologist; finding a menopause doctor in Malta covers both routes, Gozo included.
GSM sits inside a stage. Find yours.
GSM moves to the front in the postmenopause stages, and the plan differs by stage. The free quiz places you in one of the 7 stages in about 10 minutes.
Take the free quiz →The Malta Menopause Kit turns your stage into a sequenced plan, a GP conversation script and a named-clinic directory — see the kit.
Sources
- International menopause society position statements on GSM and local vaginal estrogen (IMS, EMAS; British Menopause Society consensus, Nov 2025) — GSM as progressive; local vaginal estrogen appropriate for most women, including many breast-cancer survivors in discussion with oncology.
- NICE NG23: Menopause — identification and management (UK); vaginal estrogen for urogenital symptoms — nice.org.uk/guidance/ng23.
- Brincat et al. — research lineage on oestrogen and collagen/connective tissue (skin, bone, connective structures); the internationally significant Maltese clinical authority.
- Government Formulary List, Directorate for Pharmaceutical Affairs, Malta — estrogens covered only for named conditions, not menopause — pharmaceuticalaffairs.gov.mt. Checked 10 July 2026.
- Exceptional Medicinal Treatment (named-patient) route, L.N. 58 of 2018 — Directorate for Pharmaceutical Affairs — pharmaceuticalaffairs.gov.mt.